Elsevier

Brain Research

Volume 793, Issues 1–2, 18 May 1998, Pages 315-320
Brain Research

Short communication
Contribution of the glycine site of NMDA receptors in rostral and intermediate-caudal parts of the striatum to the regulation of muscle tone in rats

https://doi.org/10.1016/S0006-8993(98)00240-6Get rights and content

Abstract

The aim of the present study was to assess the contribution of the glycine site of NMDA receptors in the striatum to the regulation of muscle tone. Muscle tone was examined using a combined mechano and electromyographic method, which measured simultaneously the muscle resistance (MMG) of the rat's hind foot to passive extension and flexion in the ankle joint and the electromyographic activity (EMG) of the antagonistic muscles of that joint: gastrocnemius and tibialis anterior. Muscle rigidity was induced by haloperidol (2.5 mg/kg i.p.). 5,7-dichlorokynurenic acid (5,7-DCKA), a selective glycine site antagonist, injected in doses of 2.5 and 4.5 μg/0.5 μl bilaterally, into the rostral region of the striatum, decreased both the haloperidol-induced muscle rigidity (MMG) and the enhanced electromyographic activity (EMG). 5,7-DCKA injected bilaterally in a dose of 4.5 μg/0.5 μl into the intermediate-caudal region of the striatum of rats not pretreated with haloperidol had no effect on the muscle tone. The present results suggest that blockade of the glycine site of NMDA receptors in the rostral part of the striatum may be mainly responsible for the antiparkinsonian action of this drug.

Section snippets

Acknowledgements

This study is part of the statutory activity of the Institute of Pharmacology of the Polish Academy of Sciences, Kraków. The authors are grateful to Dr. Krystyna Ossowska for her valuable critical remarks during the preparation of the manuscript.

References (25)

  • O. Hornykiewicz et al.

    Biochemical pathophysiology of Parkinson's disease

    Adv. Neurol.

    (1986)
  • T. Klockgether et al.

    NMDA antagonist potentiate antiparkinsonian actions of l-DOPA in monoamine-depleted rats

    Ann. Neurol.

    (1990)
  • Cited by (0)

    View full text